Breast implants were actually shown to be associated with a decreased breast cancer risk.
Ads by Google
Estrogen alone hormone therapy does not increase the risk of breast cancer in postmenopausal women.
A hormone receptor with regulatory roles as diverse as food intake, fear response, and cardiovascular function may also be involved in breast cancer.
Some breast cancer cells once fueled by estrogen can be killed by the same hormone.
New prediction model assists doctors in determining the chance of recurrence of cancer in high risk breast cancer patients who have undergone a mastectomy followed by radiation therapy.
The expression of two novel genes within the tumors of women with early stage breast cancer may allow identification of women who are and are not at risk for early relapse or cancer related death.
Ultrasound provides a safe and accurate method of detecting breast cancers in pregnant women, as well as assessing response to chemotherapy.
An enzyme that is key to a common form of breast cancer appears to be halted by a pain killing medication.
The human epidermal growth factor receptor 2 (Her 2) is an established oncogene whose overexpression drives metastasis in about 25% of breast cancer patients.
It has been estimated that 70 per cent of patients with progressive breast cancer develop bone metastases.
The percentage of women with breast cancer participating in online support groups is significant and has been growing steadily over the past decade.
Women with breast cancer who participate in computer support groups can obtain emotional benefits when they openly express themselves in ways that help them make sense of their cancer experience.
Weight gain of more than 24 pounds in women older than 50 years of age, regardless of baseline weight at age 50, is associated with a 62 percent increased risk for postmenopausal breast cance.
One additional serving of French fries per week increased breast cancer risk by 27 percent.
The farther away a woman lives from a radiation therapy facility, the less likely she is to get lumpectomy with adjuvant radiation therapy for early stage breast cancer.
A new American Cancer Society study finds low fat dairy products may reduce the risk of postmenopausal breast cancer.
The influence of the family in the treatment decision making process for breast cancer may account the significant racial differences in breast cancer management.
Study showed that the long term contralateral breast cancer risk was significantly higher in women with hereditary breast cancer compared to the risk of developing a primary breast cancer in the general population.
Ten years after the identification of the first breast cancer susceptibility genes, so few high risk minority women have received genetic testing that the standard methods of calculating risk have not been validated.
The complete analysis of data from an international trial of the drug letrozole (Femara) confirms earlier reports that the drug reduced the recurrence of breast cancer in women previously treated with tamoxifen.
Protocol could determine need for additional screening, preventive treatment for breast and ovarian cancer.
One of the most commonly administered drugs for breast cancer, tamoxifen, may not be as effective for women who inherit a common genetic change.
The results of clinical trials established the value of two types of breast cancer drugs in preventing breast cancer recurrence, improving disease free survival rates.
Although it is widely agreed that breast screening can reduce deaths, more discussion around this negative side effect of screening is needed.
Young Age and Breast Conserving Therapy Are Risk Factors for Loco-Regional Recurrences of Breast Cancer
There is an increase in loco regional recurrences in women treated with breast conserving therapy compared to mastectomy but without an adverse affect on survival.
Risk of breast cancer was not significantly reduced among postmenopausal women assigned to a diet low in fat and high in fruits.